Cargando…
Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia
BACKGROUND: Overall cure rates in acute myeloid leukemia (AML) continue to range between 60-65% with disease relapse being a major cause of mortality. The PI3K-Akt-mTOR kinase pathway plays a vital role in pro-survival signals within leukemic cells and inhibition of this pathway is being investigate...
Autores principales: | Sabnis, Himalee, Bradley, Heath L, Bunting, Silvia T, Cooper, Todd M, Bunting, Kevin D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080754/ https://www.ncbi.nlm.nih.gov/pubmed/24923301 http://dx.doi.org/10.1186/1479-5876-12-166 |
Ejemplares similares
-
Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia
por: Wang, Zhengqi, et al.
Publicado: (2021) -
Acute Myeloid Leukemia in an Infant with t(8;19)(p11.2;q13) Translocation: Case Report and a Review of the Literature
por: Eason, Ashley C., et al.
Publicado: (2019) -
Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012) -
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
por: Sabnis, Himalee S., et al.
Publicado: (2017) -
Inline Positive End-Expiratory Pressure Valves: The Essential Component of Individualized Split Ventilator Circuits
por: Roy, Steven, et al.
Publicado: (2020)